Holen Sie sich die Stockscreener-App
0.8815
4.28%
-0.0394
Handel nachbörslich:
2.58
1.6985
+192.68%
Schlusskurs vom Vortag:
$0.9209
Offen:
$0.9215
24-Stunden-Volumen:
195.55K
Relative Volume:
0.06
Marktkapitalisierung:
$8.93M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-1.13M
KGV:
-1.9201
EPS:
-0.4591
Netto-Cashflow:
$-4.60M
1W Leistung:
+19.44%
1M Leistung:
-20.59%
6M Leistung:
-20.59%
1J Leistung:
-46.90%
1-Tages-Spanne:
$0.8803
$0.9364
1-Wochen-Bereich:
$0.7005
$0.9801
52-Wochen-Spanne:
$0.63
$1.90
Pharmacyte Biotech Inc Stock (PMCB) Company Profile
Firmenname
Pharmacyte Biotech Inc
Sektor
Branche
Telefon
(917) 595.2850
Adresse
3960 HOWARD HUGHES PARKWAY, LAS VEGAS
Vergleichen Sie PMCB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| 2.24 | 0 | 0 | 0 | 0 | 0.00 | |
MOBBW
Mobilicom Limited Warrants
|
3.65 | 4.83B | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
4.66 | 416.27M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
GOODO
Gladstone Commercial Corporation
|
20.75 | 372.90M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
8.57 | 357.42M | 0 | 0 | 0 | 0.00 |
|
DWLD
Davis Select Worldwide ETF
|
47.51 | 0 | 0 | 0 | 0 | 0.00 |
Pharmacyte Biotech Inc Aktie (PMCB) Neueste Nachrichten
Hedge Fund and Insider Trading News: Paul Singer, Steve Cohen, Israel Englander, Ray Dalio, Rokos Capital Management, Viking Global, PharmaCyte Biotech Inc (PMCB), Cloudflare Inc (NET), and More - Insider Monkey
Why PharmaCyte Biotech Inc. stock could see breakout soonJuly 2025 Retail & Daily Growth Stock Tips - ulpravda.ru
Why PharmaCyte Biotech Inc. stock appeals to analystsJuly 2025 Outlook & Technical Entry and Exit Tips - ulpravda.ru
Will PharmaCyte Biotech Inc. stock rally after Fed decisionsWeekly Stock Report & Low Drawdown Trading Strategies - ulpravda.ru
How currency fluctuations impact PharmaCyte Biotech Inc. stockEarnings Summary Report & Long-Term Safe Investment Ideas - ulpravda.ru
Will PharmaCyte Biotech Inc. stock keep outperforming rivals2025 Sector Review & Risk Controlled Stock Alerts - ulpravda.ru
Jonathan Schechter buys PharmaCyte Biotech shares worth $48,232 By Investing.com - Investing.com Nigeria
PMCB Stock Insider Trading Activity - Quiver Quantitative
Pharmacyte Biotech CEO Silverman buys $80k in shares By Investing.com - Investing.com Nigeria
Pharmacyte Biotech CEO Silverman buys $80k in shares - Investing.com
How institutional buying supports PharmaCyte Biotech Inc. stockEarnings Per Share Trends & Minimal Investment Trading Tips - ulpravda.ru
PharmaCyte Biotech Inc. (PMCB) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
PharmaCyte Biotech (PMCB) Stock Analysis Report | Financials & Insights - Benzinga
Largest borrow rate increases among liquid names - TipRanks
Will PharmaCyte Biotech Inc. stock benefit from infrastructure spending2025 Top Gainers & Weekly Breakout Watchlists - Улправда
Is PharmaCyte Biotech Inc. stock positioned for digital transformation2025 Trading Recap & Free Community Supported Trade Ideas - Улправда
How PharmaCyte Biotech Inc. stock reacts to job market dataJuly 2025 Pullbacks & Reliable Entry Point Trade Alerts - Улправда
How sustainable is PharmaCyte Biotech Inc. stock dividend payoutVolume Spike & Weekly Momentum Stock Picks - Улправда
Why PharmaCyte Biotech Inc. stock is a value investor pickShare Buyback & Expert Verified Stock Movement Alerts - Улправда
PharmaCyte Biotech, Inc. SEC 10-Q Report - TradingView — Track All Markets
Movement Recap: How sustainable is PharmaCyte Biotech Inc. stock dividend payoutJuly 2025 Chart Watch & Real-Time Stock Price Movement Reports - Улправда
PharmaCyte Biotech delays quarterly report filing - MSN
PharmaCyte Biotech Delays Quarterly Report Filing - TipRanks
PharmaCyte Biotech (PMCB) files notice of late Form 10-Q under Rule 12b-25 - Stock Titan
Dir Walker Surrenders 16,875 Of PharmaCyte Biotech Inc [PMCB] - TradingView — Track All Markets
PharmaCyte Biotech (PMCB) CEO nets 316,250 shares after tax withholding - Stock Titan
PharmaCyte Biotech faces NASDAQ non-compliance notice - MSN
Healthy Upside Potential: PharmaCyte Biotech Inc (PMCB) - setenews.com
PharmaCyte’s Successful Stake Earns them Millions - StocksToTrade
PharmaCyte Biotech Faces Nasdaq Non-Compliance Notice - TipRanks
PharmaCyte Biotech’s Potential Explored Amidst Market Movements - timothysykes.com
PharmaCyte Boosts Financial Position with Femasys Stake Sale - timothysykes.com
PMCB Stock Jumps 25% After Company Sells Stake In Femasys - MSN
PharmaCyte Biotech: Is Growth Here to Stay? - StocksToTrade
Why PharmaCyte Biotech Inc. stock appeals to dividend seekers2025 Institutional Moves & Consistent Profit Trade Alerts - Newser
PharmaCyte Biotech (OTCMKTS:PMCBD) Trading Down 6.1% – Here’s What Happened - Defense World
Take off with PharmaCyte Biotech Inc (PMCB): Get ready for trading - Setenews
How does IO Biotech Inc (IOBT) change from a tortoise to a hare? - Setenews
Is PharmaCyte Biotech Inc a good long term investmentVolatility Adjusted Trading & High Profit Market Ideas - earlytimes.in
PharmaCyte Biotech stock surges following profitable exit from Femasys investment - MSN
PharmaCyte Biotech - The Pharma Letter
Finanzdaten der Pharmacyte Biotech Inc-Aktie (PMCB)
Umsatz
Nettogewinn
Free Cashflow
ENV
Pharmacyte Biotech Inc-Aktie (PMCB) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Silverman Joshua | CEO and President |
Jan 06 '26 |
Buy |
0.79 |
30,000 |
23,667 |
376,250 |
| Silverman Joshua | CEO and President |
Jan 05 '26 |
Buy |
0.78 |
30,000 |
23,493 |
346,250 |
| SCHECHTER JONATHAN | Director |
Jan 07 '26 |
Buy |
0.84 |
20,000 |
16,872 |
192,500 |
| SCHECHTER JONATHAN | Director |
Jan 06 '26 |
Buy |
0.79 |
20,000 |
15,808 |
172,500 |
| SCHECHTER JONATHAN | Director |
Jan 05 '26 |
Buy |
0.78 |
20,000 |
15,552 |
152,500 |
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):